Home Danaher Reports Strong Q1 2024 Results with $5.8 Billion in Revenue and Advances in CRISPR and Organoid Technologies

Danaher Reports Strong Q1 2024 Results with $5.8 Billion in Revenue and Advances in CRISPR and Organoid Technologies

Apr 30, 2024 11:39 CST Updated 11:39
Danaher

Product Design and Manufacturer